{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:04:11Z","timestamp":1777493051946,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:00:00Z","timestamp":1521676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1038\/s41416-018-0047-4","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T02:21:40Z","timestamp":1522808500000},"page":"1391-1398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Trends and projections in adenocarcinoma and squamous cell carcinoma of the oesophagus in England from 1971 to 2037"],"prefix":"10.1038","volume":"118","author":[{"given":"Judith","family":"Offman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Pesola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Sasieni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,22]]},"reference":[{"key":"47_CR1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1136\/gutjnl-2014-308124","volume":"64","author":"M Arnold","year":"2015","unstructured":"Arnold, M., Soerjomataram, I., Ferlay, J. & Forman, D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut 64, 381\u2013387 (2015).","journal-title":"Gut"},{"key":"47_CR2","unstructured":"Cancer Research UK (2015) Oesophageal cancer statistics Vol. Retrieved 25 November 2015. \n                    http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/oesophageal-cancer"},{"key":"47_CR3","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.3748\/wjg.v19.i34.5598","volume":"19","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. Epidemiology of esophageal cancer. World J. Gastroenterol. 19, 5598\u20135606 (2013).","journal-title":"World J. Gastroenterol."},{"key":"47_CR4","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1136\/gutjnl-2012-302412","volume":"62","author":"G Edgren","year":"2013","unstructured":"Edgren, G., Adami, H.-O., Weiderpass, E. & Nyr\u00e9n, O. A global assessment of the oesophageal adenocarcinoma epidemic. Gut 62, 1406\u20131414 (2013).","journal-title":"Gut"},{"key":"47_CR5","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1158\/1055-9965.EPI-13-1233","volume":"23","author":"CY Kong","year":"2014","unstructured":"Kong, C. Y. et al. Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling. Cancer Epidemiol. Biomark. Prev. 23, 997\u20131006 (2014).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"47_CR6","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1155\/2012\/649108","volume":"26","author":"MC Otterstatter","year":"2012","unstructured":"Otterstatter, M. C. et al. Esophageal cancer in Canada: trends according to morphology and anatomical location. Can. J. Gastroenterol. 26, 723\u2013727 (2012).","journal-title":"Can. J. Gastroenterol."},{"key":"47_CR7","first-page":"2461","volume":"12","author":"WM Mao","year":"2011","unstructured":"Mao, W. M., Zheng, W. H. & Ling, Z. Q. Epidemiologic risk factors for esophageal cancer development. Asian Pac. J. Cancer Prev. 12, 2461\u20132466 (2011).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"47_CR8","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1136\/gutjnl-2011-300730","volume":"61","author":"TK Desai","year":"2012","unstructured":"Desai, T. K. et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett\u2019s oesophagus: a meta-analysis. Gut 61, 970\u2013976 (2012).","journal-title":"Gut"},{"key":"47_CR9","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","volume":"365","author":"F Hvid-Jensen","year":"2011","unstructured":"Hvid-Jensen, F., Pedersen, L., Drewes, A. M., Sorensen, H. T. & Funch-Jensen, P. Incidence of adenocarcinoma among patients with Barrett\u2019s esophagus. N. Engl. J. Med. 365, 1375\u20131383 (2011).","journal-title":"N. Engl. J. Med."},{"key":"47_CR10","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1158\/1055-9965.EPI-05-0860","volume":"15","author":"A Kubo","year":"2006","unstructured":"Kubo, A. & Corley, D. A. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidem Biomar 15, 872\u2013878 (2006).","journal-title":"Cancer Epidem Biomar"},{"key":"47_CR11","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.cgh.2012.11.014","volume":"11","author":"F Kastelein","year":"2013","unstructured":"Kastelein, F. et al. Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett\u2019s esophagus. Clin. Gastroenterol. Hepatol. 11, 382\u2013388 (2013).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"47_CR12","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/j.1365-2036.2009.04100.x","volume":"30","author":"C Gajperia","year":"2009","unstructured":"Gajperia, C., Barbiere, J. M., Greenberg, D., Wright, K. & Lyratzopoulos, G. Recent incidence trends and sociodemographic features of oesophageal and gastric cancer types in an English region. Aliment. Pharmacol. Ther. 30, 873\u2013880 (2009).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"47_CR13","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1046\/j.1365-2036.2003.01521.x","volume":"17","author":"A Newnham","year":"2003","unstructured":"Newnham, A., Quinn, M., Babb, P., Kang, J. & Majeed, A. Trends in the subsite and morphology of oesophageal and gastric cancer in England and Wales 1971-1998. Aliment. Pharmacol. Ther. 17, 665\u2013676 (2003).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"47_CR14","unstructured":"World Health Organisation (2015) International Classification of Diseases (ICD) Vol. Retrieved 16 November 2015. \n                    http:\/\/www.who.int\/classifications\/icd\/en\/\n                    \n                  ."},{"key":"47_CR15","unstructured":"Office for National Statistics (2014) Mid-1971 to Mid-2013 Population Estimates for UK, constituent countries and English regions. Retrieved 15 May 2015. \n                    http:\/\/www.ons.gov.uk\/ons\/about-ons\/business-transparency\/freedom-of-information\/what-can-i-request\/published-ad-hoc-data\/pop\/september-2014\/mid-1971-to-mid-2013-population-estimates-for-uk--constituent-countries-and-english-regions.xls\n                    \n                  ."},{"key":"47_CR16","unstructured":"Office for National Statistics (2013) 2012-based National Population Projections. Retrieved 12 June 2015. \n                    http:\/\/www.ons.gov.uk\/ons\/rel\/npp\/national-population-projections\/2012-based-projections\/rft-table-a2-4-principal-projection---england-population-in-age-groups.xls"},{"key":"47_CR17","unstructured":"American Cancer Society Manual of tumour nomenclature and coding (ACS, New York, 1951)."},{"key":"47_CR18","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/jech.55.6.414","volume":"55","author":"HO Dickinson","year":"2001","unstructured":"Dickinson, H. O. et al. How complete and accurate are cancer registrations notified by the National Health Service Central Register for England and Wales? J. Epidemiol. Community Health 55, 414\u2013422 (2001).","journal-title":"J. Epidemiol. Community Health"},{"key":"47_CR19","unstructured":"World Health Organisation International Classification of Diseased for Oncology, first edition (WHO, Geneva, 1976)"},{"key":"47_CR20","unstructured":"World Health Organisation International Classification of Diseased for Oncology, second edition. (WHO, Geneva, 1990)"},{"key":"47_CR21","unstructured":"World Health Organisation International Classification of Diseased for Oncology, third edition. (WHO, Geneva, 2013)"},{"key":"47_CR22","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1038\/bjc.2011.430","volume":"105","author":"M Mistry","year":"2011","unstructured":"Mistry, M., Parkin, D. M., Ahmad, A. S. & Sasieni, P. Cancer incidence in the United Kingdom: projections to the year 2030. Br. J. Cancer 105, 1795\u20131803 (2011).","journal-title":"Br. J. Cancer"},{"key":"47_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/1536867X1201200104","volume":"12","author":"P Sasieni","year":"2012","unstructured":"Sasieni, P. Age\u2013period\u2013cohort models in Stata. Stata J. 12, 45\u201360 (2012).","journal-title":"Stata J."},{"key":"47_CR24","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1002\/sim.1481","volume":"22","author":"B Moller","year":"2003","unstructured":"Moller, B. et al. Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Stat. Med. 22, 2751\u20132766 (2003).","journal-title":"Stat. Med."},{"key":"47_CR25","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1177\/1536867X1801700416","volume":"17","author":"P Sasieni","year":"2017","unstructured":"Sasieni, P. Software Updates. Stata J. 17, 1024\u20131024 (2017).","journal-title":"Stata J."},{"key":"47_CR26","unstructured":"Bray, F in Age-standardization (ed. D. M. Parkin) Ch. 3, 87\u201389 (IARC, Lyon, 2002.)."},{"key":"47_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1158\/1055-9965.EPI-15-0753","volume":"25","author":"M Arnold","year":"2016","unstructured":"Arnold, M. et al. Obesity and the incidence of upper gastrointestinal cancers: an ecological approach to examine differences across age and sex. Cancer Epidemiol. Biomark. 25, 90\u201397 (2016).","journal-title":"Cancer Epidemiol. Biomark."},{"key":"47_CR28","unstructured":"Health and Social Care Information Centre Statistics on Obesity, Physical Activity and Diet (NHS Digital, England, 2016)"},{"key":"47_CR29","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1136\/gutjnl-2013-306393","volume":"63","author":"G Boeckxstaens","year":"2014","unstructured":"Boeckxstaens, G., El-Serag, H. B., Smout, A. J. P. M. & Kahrilas, P. J. Symptomatic reflux disease: the present, the past and the future. Gut 63, 1185\u20131193 (2014).","journal-title":"Gut"},{"key":"47_CR30","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/gut.2004.051821","volume":"54","author":"J Dent","year":"2005","unstructured":"Dent, J., El-Serag, H. B., Wallander, M.-A. & Johansson, S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 54, 710\u2013717 (2005).","journal-title":"Gut"},{"key":"47_CR31","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1136\/gutjnl-2013-305997","volume":"63","author":"S Singh","year":"2014","unstructured":"Singh, S., Garg, S. K., Singh, P. P., Iyer, P. G. & El-Serag, H. B. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett\u2019s oesophagus: a systematic review and meta-analysis. Gut 63, 1229\u20131237 (2014).","journal-title":"Gut"},{"key":"47_CR32","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/pds.4043","volume":"25","author":"F Othman","year":"2016","unstructured":"Othman, F., Card, T. R. & Crooks, C. J. Proton pump inhibitor prescribing patterns in the UK: a primary care database study. Pharmacoepidemiol. Drug. Saf. 25, 1079\u20131087 (2016).","journal-title":"Pharmacoepidemiol. Drug. Saf."},{"key":"47_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/(SICI)1097-0215(19990827)82:5<657::AID-IJC7>3.0.CO;2-C","volume":"82","author":"X Castellsagu\u00e9","year":"1999","unstructured":"Castellsagu\u00e9, X. et al. Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int. J. Cancer 82, 657\u2013664 (1999).","journal-title":"Int. J. Cancer"},{"key":"47_CR34","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/apt.12514","volume":"38","author":"A Prabhu","year":"2013","unstructured":"Prabhu, A., Obi, K. O. & Rubenstein, J. H. Systematic review with meta-analysis: race-specific effects of alcohol and tobacco on the risk of oesophageal squamous cell carcinoma. Aliment. Pharmacol. Ther. 38, 1145\u20131155 (2013).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"47_CR35","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/annonc\/mdm578","volume":"19","author":"GD Batty","year":"2008","unstructured":"Batty, G. D. et al. Cigarette smoking and site-specific cancer mortality: testing uncertain associations using extended follow-up of the original Whitehall study. Ann. Oncol. 19, 996\u20131002 (2008).","journal-title":"Ann. Oncol."},{"key":"47_CR36","unstructured":"The Health and Social Care Information Centre Statistics on Smoking (NHS Digital, England, 2013)."},{"key":"47_CR37","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s11605-013-2345-8","volume":"18","author":"A Dubecz","year":"2014","unstructured":"Dubecz, A. et al. Does the incidence of adenocarcinoma of the esophagus and gastric cardia continue to rise in the Twenty-First Century?\u2014a SEER database analysis. J. Gastrointest. Surg. 18, 124\u2013129 (2014).","journal-title":"J. Gastrointest. Surg."},{"key":"47_CR38","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1002\/cncr.27834","volume":"119","author":"C Hur","year":"2013","unstructured":"Hur, C. et al. Trends in esophageal adenocarcinoma incidence and mortality. Cancer 119, 1149\u20131158 (2013).","journal-title":"Cancer"},{"key":"47_CR39","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/ajg.2013.420","volume":"109","author":"S Kroep","year":"2014","unstructured":"Kroep, S. et al. Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and The Netherlands. Am. J. Gastroenterol. 109, 336\u2013343 (2014).","journal-title":"Am. J. Gastroenterol."},{"key":"47_CR40","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1158\/1055-9965.EPI-16-0520","volume":"26","author":"AM Noone","year":"2017","unstructured":"Noone, A.-M. et al. Cancer incidence and survival trends by subtype using data from the surveillance epidemiology and end results program, 1992\u20132013. Cancer Epidemiol. Biomark. 26, 632\u2013641 (2017).","journal-title":"Cancer Epidemiol. Biomark."},{"key":"47_CR41","first-page":"669","volume":"22","author":"J Steevens","year":"2010","unstructured":"Steevens, J., Botterweck, A. A. M., Dirx, M. J. M., van den Brandt, P. A. & Schouten, L. J. Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur. J. Gastroenterol. Hepatol. 22, 669\u2013678 (2010).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"47_CR42","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/ajg.2017.155","volume":"112","author":"M Arnold","year":"2017","unstructured":"Arnold, M., Laversanne, M., Brown, L. M., Devesa, S. S. & Bray, F. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030. Am. J. Gastroenterol. 112, 1247\u20131255 (2017).","journal-title":"Am. J. Gastroenterol."},{"key":"47_CR43","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1093\/annonc\/mds181","volume":"23","author":"AP Thrift","year":"2012","unstructured":"Thrift, A. P. & Whiteman, D. C. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann. Oncol. 23, 3155\u20133162 (2012).","journal-title":"Ann. Oncol."},{"key":"47_CR44","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1002\/ijc.23691","volume":"123","author":"KF Trivers","year":"2008","unstructured":"Trivers, K. F., Sabatino, S. A. & Stewart, S. L. Trends in esophageal cancer incidence by histology, United States, 1998\u20132003. Int. J. Cancer 123, 1422\u20131428 (2008).","journal-title":"Int. J. Cancer"},{"key":"47_CR45","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ijc.10427","volume":"99","author":"AP Vizcaino","year":"2002","unstructured":"Vizcaino, A. P., Moreno, V., Lambert, R. & Parkin, D. M. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973\u20131995. Int. J. Cancer 99, 860\u2013868 (2002).","journal-title":"Int. J. Cancer"},{"key":"47_CR46","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1080\/11024150152707725","volume":"167","author":"C Walther","year":"2001","unstructured":"Walther, C., Zilling, T., Perfekt, R. & M\u00f6ller, T. Increasing prevalence of adenocarcinoma of the oesophagus and gastro-oesophageal junction: a study of the Swedish population between 1970 and 1997. Eur. J. Surg. 167, 748\u2013757 (2001).","journal-title":"Eur. J. Surg."},{"key":"47_CR47","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.canep.2017.02.004","volume":"47","author":"SH Xie","year":"2017","unstructured":"Xie, S.-H., Mattsson, F. & Lagergren, J. Incidence trends in oesophageal cancer by histological type: an updated analysis in Sweden. Cancer Epidemiol. 47, 114\u2013117 (2017).","journal-title":"Cancer Epidemiol."},{"key":"47_CR48","unstructured":"American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th Edition (Springer, Chicago, 2002) ."},{"key":"47_CR49","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1245\/s10434-010-1024-1","volume":"17","author":"TW Rice","year":"2010","unstructured":"Rice, T. W., Blackstone, E. H. & Rusch, V. W. 7th Edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann. Surg. Oncol. 17, 1721\u20131724 (2010).","journal-title":"Ann. Surg. Oncol."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41416-018-0047-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-018-0047-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-018-0047-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:02:07Z","timestamp":1684616527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-018-0047-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,22]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["47"],"URL":"https:\/\/doi.org\/10.1038\/s41416-018-0047-4","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,22]]},"assertion":[{"value":"2 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The data set used here can be obtained from the PHE Office for Data Release. The authors can provide data specifications for any data requests to the Office of Data Release.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data"}}]}}